Efficacy and safety of immune checkpoint inhibitors in colorectal cancer: a systematic review and meta-analysis

BACKGROUND AND OBJECTIVE: Immune checkpoint inhibitor (ICI) therapies have shown promising prospects in colorectal cancer (CRC) immunotherapy; many clinical trials have been carried out. In this study, we sought to evaluate the efficacy and safety of ICI therapies in CRC by presenting a meta-analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Tianni, Fang, Xiaojie, Lu, Jinhua, Zhong, Yazhen, Lin, Xianlei, Lin, Zechen, Wang, Nan, Jiang, Jing, Lin, Shengyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760220/
https://www.ncbi.nlm.nih.gov/pubmed/34716473
http://dx.doi.org/10.1007/s00384-021-04028-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760220/
https://www.ncbi.nlm.nih.gov/pubmed/34716473
http://dx.doi.org/10.1007/s00384-021-04028-z

Ejemplares similares